← Back to news
Y

Yahoo Finance

Which Companies Are Sitting on the Most Cash?

Y

Apple Just Sent Investors a Message: Is The Stock a Buy?

Y

I Asked ChatGPT for the Worst Social Security Mistakes Retirees Make — And How Not To

Y

Maplebear Details AI, Ads and International Push at Morgan Stanley Event, Reiterates Buybacks

Y

Nextech3D.ai expands into outdoor event market - ICYMI

Y

Bank of America Is Bullish on Tesla Again. Is That a Reason to Buy TSLA Stock?

Y

Stablecoin firms bet big on AI agent payments that barely exist

Y

‘The Irony’: ACV Auctions CEO’s AI Rebuttal Couldn’t Stop a 36% Slide

Y

The Mid-Cap Dividend ETF That’s Been Quietly Beating Schwab’s SCHD ETF Lately

Y

3 Smart Tax Strategies Homeowners Can Use in the Next 12 Months

Y

How a Former EMT Just Sank a Bunch of Stocks on AI Fears

Y

IREN’s $6 Billion Stock Offering: Is This AMC Entertainment 2.0 for the AI Era?

Y

Had You Invested $1,000 in Coca-Cola or PepsiCo 10 Years Ago, Here’s What You’d Have Today

Y

Meet the Artificial Intelligence (AI) ETF With 20% of Its Portfolio Parked in Alphabet, Nvidia, Micron, and Amazon

Y

Jefferies Financial comments on Western Alliance lawsuit

Y

Marvell price target raised to $135 from $130 at B. Riley

Y

1 Growth Stock Down 60% You'll Wish You'd Bought on the Dip, According to Wall Street

Y

Carlsmed Unveils Personalized Spine Platform, Targets $70M-$75.5M 2025 Revenue at Conference

Y

Meta Wants To Build Its Own AI Chips - Here's Why

Y

Howard Marks says don’t let war ‘affect your emotions’ around investing. How to stay the course during turbulent times

Y

EPR Properties price target raised to $62 from $60 at Truist

Y

ServiceTitan offers attractive monetization opportunities, says Truist

Y

ALX Oncology initiated with a Buy at UBS

Y

Albemarle discipline on costs to continue, says Truist

Y

AAR Corp. price target raised to $128 from $107 at Truist

Y

Alpha Modus resolves patent infringement litigation against Brookshire

Y

AudioEye price target lowered to $15.50 from $19 at B. Riley

Y

Cooper Companies price target raised to $101 from $99 at Needham

Y

Artelo Biosciences announces 3-for-1 reverse stock split

Y

Mammoth Energy reports Q4 cont ops EPS (26c) vs. (20c) last year

Y

Cheniere Energy Partners price target raised to $62 from $58 at RBC Capital

Y

23-year-old inherited $450K, parked it and doesn't know what to do next. What Dave Ramsey says will get the 'most lift'

Y

Stock Market Focus On Iran War News. Oil's Next Move Could Be Big.

Y

3 Vanguard ETFs to Buy and Hold Forever for $30,000 in Annual Dividend Income

Y

Robinhood Unveils New Platinum Card Offering $250 Autonomous Ride Credit, TSA PreCheck Access, Cashbacks—Here's What You Need To Know

Y

General Dynamics Leads 5 Stocks Near Buy Points Amid Iran War Sell-Off

Y

4 Tax Refund Scams To Watch Out For

Y

3 Risks That Could Erode Walmart's Long-Term Competitive Advantage

Y

Cheesecake Factory Touts 26 Openings, Off-Premise Momentum and Bigger Buybacks at Raymond James Conf.

Y

XRP Price Prediction: 5 Catalysts That Could Push XRP to $3 in 2026

Y

Medicare’s 2026 Cost Jump Strains Social Security Budgets

Y

Fixed costs gobble up a staggering 92% of high-earning couple's income. Ramit Sethi explains what's blocking their path

Y

Prediction Markets Are Here to Stay, but This Stock Is a Better Way to Play the Trend

Y

MTG flags imminent Social Security crisis — urges US to stop ‘funding foreign wars’ to save the program. Secure your inc

Y

The US is the world’s biggest oil producer — so why are gas prices rising here?

Y

Trump Ally Mullin Goes Stock Shopping Again: Here's His Latest Buys, Including Potential Conflict Of Interest

Y

We just learned my dad had a life insurance policy, 12 years later. Has the window closed with the insurer?

Y

TX woman is inheriting $200K and wonders whether to pay off her house or invest. The Ramsey Show says ‘buy time’ instead

Y

Why Retirees Who Only Own ETFs May Be Missing a Key Income Layer

Y

Tempus AI, Inc. (TEM) Announces Strategic Deal with Merck to Fast-Track AI-Driven Precision Medicine

Y